FDA Drops Hammer on ‘Latex Free’ Claim
March 18, 2013 The claim “latex-free” is impossible to guarantee and should not be used on labeling of medical products, according to new guidance from the U.S. Food and Drug Administration. “FDA is aware of no test method or combination of test methods available at this time that can demonstrate the absence of proteins or […]
Read More »Category : News
About that 15 Day Response Time for FDA 483s? FDA Means It!
March, 18, 2013 It always amazes me. The pharmaceutical industry is full of some of the brightest and most dedicated professionals in any industry anywhere. However, some of the simplest FDA regulations can trip up some very smart people at some very big companies. The biggest example I can think of is one that our […]
Read More »Category : News
Like Candy at Easter – FDA Hands Out CAPA 483 Observations
Latest FDA and cGMP Compliance News Avoid a CAPA Inspection Disaster With a Closed Loop, FDA Compliant CAPA System, and Learn 7 Powerful Tools for Root Cause Analysis In the recent past, it seems that FDA has thought that if it focused a great deal on CAPA, it would solve many of the problems in […]
Read More »Category : Compliance Tips &News
Industry Bafflement by CDRH eCopy Rule Continues; FDA Confused, As Well
March 18, 2013 You probably know by now that CDRH now requires eCopy for most submissions since Jan. 1, 2013. Our electronics submissions expert, Antoinette Azevedo, has been informing us of some of the chaos that surrounds the new requirement both in the industry and at FDA (see our post on eCopy last week). As […]
Read More »Category : Compliance Tips &News
KV Pharma Attacks FDA – Again!
How the Quality Manager Gets Canned If at first you don’t succeed… KV Pharmaceutical is not giving up in its fight with the FDA. The embattled drugmaker is appealing the dismissal last fall of a lawsuit that claimed the agency abdicated its responsibility to prevent some compounding pharmacies from offering lower-cost versions of its controversial […]
Read More »Category : News
Teva Pays Big Bucks for Wrecking Environment
How the Quality Manager Gets Canned As increasing concern mounts over the extent to which pharmaceuticals may harm the water supply, drugmakers are being scrutinized quite closely for infractions that contribute to the problem. The latest instance involves Teva Pharmaceuticals, which agreed to pay $2.3 million to resolve a series of violations at a Missouri […]
Read More »Category : News
Why Is CDRH’s eCopy Confusing Everybody?
March 15, 2013 Avoid the CDRH eCopy Chaos! CDRH now requires eCopy for every submission since Jan. 1. According to electronic submissions expert Antoinette Azevedo, there have been instances of many eCopy holds at CDRH because of so many issues with the new format of eCopy. A hold means a delay, which means loss of […]
Read More »Category : Compliance Tips &News
FDA Chief of Generic Drugs Hits Exit After Only 8 Months
March 14, 2013 After just eight months at the FDA, Greg Geba is leaving his job as director of the Office of Generic Drugs over differences that emerged following a recent reorganization. His departure, which takes effect on Friday, comes at an inauspicious moment because the FDA, for the first time, recently began collecting user […]
Read More »Category : News
No New Boats This Year for J&J Execs – Big Pay Cuts
March 14, 2013 Citing various ‘disappointments’ and a ‘mixed’ overall performance, Johnson & Johnson lowered the bonuses given to ceo Alex Gorsky and other top execs by 10 percent. The move comes after three years of scandals, manufacturing gaffes, an FDA consent decree, shareholder lawsuits and, in particular, criticism that the compensation given to Gorksy’s […]
Read More »Category : News
FDA May Loosen Rules For Drug Approvals for Alzheimer’s – Post Marketing Trials Required
March 14, 2013 New Guidance for Alzheimer’s Disease To Require Post-Marketing Trials In a constant search for the elusive fountain of youth, FDA is planning to move forward with looser rules for drug approvals for drugs that fight Alzheimer’s disease. Last month, FDA came out with new guidelines in draft form that were posted on […]
Read More »Category : News
